158 related articles for article (PubMed ID: 34001944)
1. LIPG endothelial lipase and breast cancer risk by subtypes.
Gago-Dominguez M; Redondo CM; Calaza M; Matabuena M; Bermudez MA; Perez-Fernandez R; Torres-Español M; Carracedo Á; Castelao JE
Sci Rep; 2021 May; 11(1):10436. PubMed ID: 34001944
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions.
Gago-Dominguez M; Matabuena M; Redondo CM; Patel SP; Carracedo A; Ponte SM; Martínez ME; Castelao JE
Sci Rep; 2020 Aug; 10(1):13203. PubMed ID: 32764699
[TBL] [Abstract][Full Text] [Related]
3. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
4. LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer.
Cadenas C; Vosbeck S; Edlund K; Grgas K; Madjar K; Hellwig B; Adawy A; Glotzbach A; Stewart JD; Lesjak MS; Franckenstein D; Claus M; Hayen H; Schriewer A; Gianmoena K; Thaler S; Schmidt M; Micke P; Pontén F; Mardinoglu A; Zhang C; Käfferlein HU; Watzl C; Frank S; Rahnenführer J; Marchan R; Hengstler JG
Int J Cancer; 2019 Aug; 145(4):901-915. PubMed ID: 30653260
[TBL] [Abstract][Full Text] [Related]
5. Alcohol and breast cancer tumor subtypes in a Spanish Cohort.
Gago-Dominguez M; Castelao JE; Gude F; Fernandez MP; Aguado-Barrera ME; Ponte SM; Redondo CM; Castelo ME; Dominguez AN; Garzón VM; Carracedo A; Martínez ME
Springerplus; 2016; 5():39. PubMed ID: 26835221
[TBL] [Abstract][Full Text] [Related]
6. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
7. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
Parise C; Caggiano V
Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
[TBL] [Abstract][Full Text] [Related]
8. Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.
Dias JA; Fredrikson GN; Ericson U; Gullberg B; Hedblad B; Engström G; Borgquist S; Nilsson J; Wirfält E
PLoS One; 2016; 11(7):e0158959. PubMed ID: 27391324
[TBL] [Abstract][Full Text] [Related]
9. Association of endothelial lipase gene (LIPG) haplotypes with high-density lipoprotein cholesterol subfractions and apolipoprotein AI plasma levels in Japanese Americans.
Hutter CM; Austin MA; Farin FM; Viernes HM; Edwards KL; Leonetti DL; McNeely MJ; Fujimoto WY
Atherosclerosis; 2006 Mar; 185(1):78-86. PubMed ID: 16023652
[TBL] [Abstract][Full Text] [Related]
10. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
[TBL] [Abstract][Full Text] [Related]
11. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
12. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.
Sayed S; Fan S; Moloo Z; Wasike R; Bird P; Saleh M; Shaikh AJ; Figueroa JD; Naidoo R; Makokha FW; Gardner K; Oigara R; Njoroge FW; Magangane P; Mutebi M; Chauhan R; Mwanzi S; Govender D; Yang XR
Breast Cancer Res; 2021 Jun; 23(1):68. PubMed ID: 34174935
[TBL] [Abstract][Full Text] [Related]
14. Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels.
Mank-Seymour AR; Durham KL; Thompson JF; Seymour AB; Milos PM
Biochim Biophys Acta; 2004 Feb; 1636(1):40-6. PubMed ID: 14984737
[TBL] [Abstract][Full Text] [Related]
15. Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.
Miyagawa Y; Miyake T; Yanai A; Murase K; Imamura M; Ichii S; Takatsuka Y; Ito T; Hirota S; Saito M; Kotoura Y; Miyauchi K; Fujimoto Y; Hatada T; Sasa M; Miyoshi Y
Breast Cancer; 2015 Jul; 22(4):399-405. PubMed ID: 24000037
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
[TBL] [Abstract][Full Text] [Related]
17. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study.
Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K
Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251
[TBL] [Abstract][Full Text] [Related]
19. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
